Invention Grant
- Patent Title: Targeting microRNA-101-3p in cancer therapy
-
Application No.: US16332588Application Date: 2017-10-31
-
Publication No.: US11459568B2Publication Date: 2022-10-04
- Inventor: Louis M. Messina , Guodong Tie
- Applicant: University of Massachusetts
- Applicant Address: US MA Boston
- Assignee: University of Massachusetts
- Current Assignee: University of Massachusetts
- Current Assignee Address: US MA Boston
- Agency: Fish & Richardson P.C.
- International Application: PCT/US2017/059367 WO 20171031
- International Announcement: WO2018/081817 WO 20180503
- Main IPC: C07H21/02
- IPC: C07H21/02 ; C07H21/04 ; C12N15/113 ; A61K35/28 ; A61K45/06
Abstract:
Methods and compositions for treating cancer, e.g., colorectal cancer, using a miR-101-3p inhibitor.
Public/Granted literature
- US20210277402A1 TARGETING MICRORNA-101-3P IN CANCER THERAPY Public/Granted day:2021-09-09
Information query
